13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-14, with 38 holding rows worth $349,747,000.
- Accession
- 0001493152-18-006822
- Filer
- CIK 1595855
- Filed
- 2018-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2018
A holdings report, 38 entries on the cover page, a total value of $349,747,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $349,747,000 with VALUE read as thousands by filing date, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AXOGEN INC | 05463X106 | COM | 1,715,000 | $62,597,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 600,000 | $55,020,000 | thousands by filing date | |
| LOXO ONCOLOGY INC | 548862101 | COM | 179,400 | $20,697,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 1,700,600 | $18,706,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 360,000 | $16,632,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 1,590,000 | $14,071,000 | thousands by filing date | |
| CORIUM INTL INC | 21887L107 | COM | 1,065,000 | $12,215,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 130,000 | $10,631,000 | thousands by filing date | |
| FENNEC PHARMACEUTICALS INC | 31447P100 | COMMON STOCK | 873,000 | $10,559,000 | thousands by filing date | |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 535,000 | $10,165,000 | thousands by filing date | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 665,000 | $8,638,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163UAA4 | NOTE 2.500 2/1 | 420,000 | $8,463,000 | thousands by filing date | |
| MIRAGEN THERAPEUTICS INC | 60463E10E | COM | 1,060,000 | $7,430,000 | thousands by filing date | |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 365,000 | $7,314,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A900 | COM | 1,111,000 | $7,232,000 | thousands by filing date | |
| XOMA ROYALTY CORPORATION | 98419J206 | COMMON STOCK | 320,200 | $6,477,000 | thousands by filing date | |
| BIOFRONTERA AG | 090758105 | SPONSORED ADS | 391,200 | $6,462,000 | thousands by filing date | |
| ARDELYX INC | 039697107 | COM | 1,135,600 | $5,734,000 | thousands by filing date | |
| AUDENTES THERAPEUTICS INC. | 05070R104 | Common Stock | 190,000 | $5,709,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 1,745,000 | $5,252,000 | thousands by filing date | |
| ABLYNX NV | 00372Y905 | SPONSORED ADR | 90,000 | $4,910,000 | thousands by filing date | |
| FOAMIX PHARMACEUTICALS LTD | M46135105 | SHS | 950,000 | $4,873,000 | thousands by filing date | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 1,100,800 | $4,810,000 | thousands by filing date | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 80,000 | $4,079,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 1,095,100 | $4,063,000 | thousands by filing date | |
| DEPOMED INC | 249908104 | COM | 600,000 | $3,954,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 145,000 | $3,923,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 274,200 | $3,893,000 | thousands by filing date | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 222,500 | $3,166,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 600,000 | $3,120,000 | thousands by filing date | |
| QUANTERIX CORP | 74766Q101 | COMMON STOCK | 150,000 | $2,556,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365A101 | COM | 3,260,000 | $1,760,000 | thousands by filing date | |
| FORTRESS BIOTECH INC | 34960Q109 | COM | 315,000 | $1,433,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 70,000 | $1,242,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 74,074 | $961,000 | thousands by filing date | |
| Adobe Systems Inc | 98979H103 | COM | 100,000 | $504,000 | thousands by filing date | |
| QUOTIENT LTD | G73268107 | SHS | 60,000 | $282,000 | thousands by filing date | |
| BIOLINERX LTD-SPONS ADR | 09071M106 | SPON | 250,000 | $214,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-18-006822 | this filing | 2018-05-14 | acceptance time not in the bulk data set |